Moreover, SIRT1 has an oncogenic activity in BC cells as it inhibits the expression of the tumour suppressor gene p53 via activation of Mdm2, interfering with cell proliferation, cell cycle, apoptosis, and DNA repair, predisposing breast cells to neoplastic transformation (21, 27). This evidence concerns the gene SIRT1 and breast cancer.